LPL Financial
GOSS icon

LPL Financial’s Gossamer Bio GOSS Stock Holding History

LPL Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-563
Closed -$140K – 6056
2025
Q4 		$140K Sell
563
-62
-10% -$14.2K ﹤0.01% 5542
2025
Q3 		$132K Buy
625
+187
+43% +$33K ﹤0.01% 5448
2025
Q2 		$43K Buy
+438
New +$38.2K ﹤0.01% 5379

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

LPL Financial's GOSS Position: Q2 2026 in Review

LPL Financial reduced its Gossamer Bio (GOSS) stake by 11% in Q2 2026, selling an estimated $10.9K and leaving 4,157 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6016.

LPL Financial first reported a position in GOSS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.11M in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • LPL Financial held 4,157 shares of Gossamer Bio worth $54.7K as of Q2 2026.
  • LPL Financial sold 490 Gossamer Bio shares in Q2 2026, an estimated $10.9K.
  • Gossamer Bio made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6016 holding.
  • LPL Financial first reported a position in Gossamer Bio in Q2 2025 and has held it in 5 quarters since.
  • LPL Financial's Gossamer Bio position peaked at $1.11M in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.